Evaluation of an Ultraportable ECG Recording Device and Its Visualization Software for the Detection of Atrial Fibrillation

NCT ID: NCT03975725

Last Updated: 2019-06-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-30

Study Completion Date

2023-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose is to demonstrate the usefulness of WitCard and WitDisplayer in the diagnosis of AF but more generally in the qualification of the heart rhythm and the diagnosis of cardiac arrhythmias.

The main objective is therefore to demonstrate that at least 90 +/- 0.03% of ECGWs are interpretable by a physician and the primary endpoint will therefore be the ratio of the number of ECGWs that allowed a physician to make a diagnosis. rhythmic (ECGW interpretable) and the total number of ECGW recorded and viewed.

The clinical trial as part of the CE medical device certification process for secondary objectives and ancillary studies will be required to assess the diagnostic performance of the WitCard + WitDisplayer system, the quality of the ECGW recorded by the WitCard, the the safety of using the WitCard, the technical performance of the WitCard ECG recorder, the ergonomics of the WitCard, and finally the performance of automatic cardiac rhythm classification algorithms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Monocentric, prospective, interventional study

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Illnesses

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

witcard

Group Type EXPERIMENTAL

the use of the WitCard

Intervention Type DEVICE

electrocardiogram (ECG)

the use of WitDisplayer

Intervention Type OTHER

a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

the use of the WitCard

electrocardiogram (ECG)

Intervention Type DEVICE

the use of WitDisplayer

a software to visualize, measure, annotate, comment, archive, and share the different ECGs acquired with the WitCard (ECGW) of different patients.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient, male or female, over 18 years of age, presenting to the cardiology-rhythmology department (consultations and hospitalizations) or to the emergency department of the Timone 2 Hospital for the management of suspicion of disorder heart rate in front of:

* Palpitations
* Dyspnoea, acute pulmonary edema, non-ischemic heart failure
* Malaise, lipothymia, syncope

Exclusion Criteria

* Patients with clinical criteria that do not warrant the use of WitCard:
* Immediate vital risk whatever its nature
* Rhythmic urgency requiring treatment without delay: respiratory, circulatory or neurological distress
* Acute Coronary Syndrome
* Pregnant women
* Non-beneficiaries of a social security scheme
* Persons deprived of their liberty
* Patient participating in another study
* Patient in a period of exclusion determined by a previous study
* Patient under the protection of justice, under guardianship or under guardianship
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique Hopitaux De Marseille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

jean-olivier ARNAUD

Role: STUDY_DIRECTOR

Assistance Publique Hopitaux De Marseille

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

jean-claude deharo

Role: CONTACT

04 91 69 89 24

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-A00918-49

Identifier Type: OTHER

Identifier Source: secondary_id

2018-67

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Withings ECG-Monitor Study
NCT05316337 COMPLETED NA
Withings ECG-app Study
NCT05316350 COMPLETED NA